Dr. Stanley J. Chetcuti, MD

Dr. Chetcuti practices at University Hospital in Ann Arbor, Michigan.

Dr. Chetcuti's NPI, 1467503516, was assigned on January 16, 2007. Dr. Chetcuti graduated from University of Malta School of Medicine in 1990. Dr. Chetcuti holds Michigan license 4301072581.

Dr. Chetcuti's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

Dr. Chetcuti's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Chetcuti is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dmand AI also links Dr. Chetcuti to 3 more hospitals and 1 medical group, each named with a free account. Dr. Chetcuti's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chetcuti practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Chetcuti's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Chetcuti is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Chetcuti's licenses on file in 2 states: Michigan and Minnesota.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac catheterization, cerebrovascular disease, chronic hypertension, coronary artery disease, heart bypass surgery and heart failure among the conditions Dr. Chetcuti treats.

CMS data shows 440 Medicare services from Dr. Chetcuti across 13 procedure codes in 2024, for 258 Medicare patients. Medicare paid $62,038 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 258 Medicare patients who saw Dr. Chetcuti in 2024. The largest group is 75 to 84, with 106 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.32, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chetcuti's median patient age at 77, with 43% women.

In 2024, Dr. Chetcuti wrote 737 Medicare Part D claims for 182 patients. 93% of them were for generic drugs. CMS names the drug for 606 of them, across 18 drugs with 11 or more claims each, at $47,158 in total drug cost. In 2023, CMS named 655 claims across 19 drugs.

Dr. Chetcuti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chetcuti as offering telehealth. CMS counts 17 procedures of coronary angioplasty and stenting by Dr. Chetcuti, more than 44% of the clinicians it reports for that procedure.

Dmand AI links 94 papers to Dr. Chetcuti, published from 2005 to 2025. 2019 was the busiest year, with 10. The most frequent topics are Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis and Aortic Valve. Dr. Chetcuti has published most often in JACC Cardiovasc Interv. Dr. Chetcuti's most frequent co-authors are George Michael Deeb, MD, Steven J. Yakubov, MD and Michael Joseph Reardon, MD.

Dmand AI links Dr. Chetcuti to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Ventricular Outflow Obstruction, Aortic Valve Stenosis and Aortic Diseases. Medtronic Cardiovascular sponsors the most, 3.

CMS Open Payments shows 1,913 general payments to Dr. Chetcuti from 18 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Medtronic, Inc. paid the most, $423,709. It also lists 33 research payments totaling $26,350 from 2017 to 2023.

Dmand AI lists 2 awards for Dr. Chetcuti, most recently CMS Stage 1 EHR in 2013.

Dr. Chetcuti graduated from University of Malta School of Medicine in 1990. Dr. Chetcuti is a member of ACC.

Dr. Chetcuti is in network with 19 carriers, including Aetna, Health Alliance Plan and Priority Health. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.